Cell Culture Models for the Study of Hepatitis D Virus Entry and Infection

Defined host factors support HBV infection in non‐hepatic 293T cells

(2020) Xiaoqiang Yang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Future treatments for hepatitis delta virus infection

(2020) Tarik Asselah et al.   LIVER INTERNATIONAL

E-cadherin Plays a Role in Hepatitis B Virus Entry Through Affecting Glycosylated Sodium-Taurocholate Cotransporting Polypeptide Distribution

(2020) Qin Hu et al.   Frontiers in Cellular and Infection Microbiology

Hepatitis B virus entry into HepG2-NTCP cells requires clathrin-mediated endocytosis

(2020) Charline Herrscher et al.   CELLULAR MICROBIOLOGY

The global prevalence of hepatitis D virus infection: systematic review and meta-analysis

(2020) Alexander J. Stockdale et al.   JOURNAL OF HEPATOLOGY

In Vitro Systems for Studying Different Genotypes/Sub-Genotypes of Hepatitis B Virus: Strengths and Limitations

(2020) Constance N. Wose Kinge et al.   Viruses-Basel

Hepatitis B Virus Entry into Cells

(2020) Charline Herrscher et al.   Cells

Fast Differentiation of HepaRG Cells Allowing Hepatitis B and Delta Virus Infections

(2020) Julie Lucifora et al.   Cells

Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets

(2019) Eloi R Verrier et al.   GUT

A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection

(2019) Youki Ueda et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization

(2019) Masashi Iwamoto et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Liver organoids: from basic research to therapeutic applications

(2019) Nicole Prior et al.   GUT

Excellent safety and effectiveness of high dose myrcludex-b monotherapy administered for 48 weeks in hdv related compensated cirrhosis: a case report of three patients

(2019) Alessandro Loglio et al.   JOURNAL OF HEPATOLOGY

Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation

(2019) Florian A. Lempp et al.   Nature Communications

Generation and characterization of a stable cell line persistently replicating and secreting the human hepatitis delta virus

(2019) Yi Ni et al.   Scientific Reports

Beyond Pegylated Interferon-Alpha: New Treatments for Hepatitis Delta

(2019) Katja Deterding et al.   AIDS REVIEWS

Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection

(2019) Zhijiang Miao et al.   JOURNAL OF INFECTIOUS DISEASES

Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes

(2018) Zhenfeng Zhang et al.   JOURNAL OF HEPATOLOGY

Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis

(2018) Hai-Yan Chen et al.   GUT

Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development

(2018) Jianming Hu et al.   GASTROENTEROLOGY

ICTV Virus Taxonomy Profile: Deltavirus

(2018) Lars Magnius et al.   JOURNAL OF GENERAL VIROLOGY

Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo

(2017) Katja Giersch et al.   GUT

Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions

(2017) Yuchen Xia et al.   JOURNAL OF HEPATOLOGY

Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor

(2016) Florian A. Lempp et al.   JOURNAL OF HEPATOLOGY

The hepatitis delta virus: Replication and pathogenesis

(2016) Camille Sureau et al.   JOURNAL OF HEPATOLOGY

Experimental in vitro and in vivo models for the study of human hepatitis B virus infection

(2016) Lena Allweiss et al.   JOURNAL OF HEPATOLOGY

Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection

(2016) Eloi Verrier et al.   Viruses-Basel

Advances and Challenges in Studying Hepatitis B Virus In Vitro

(2016) Dvora Witt-Kehati et al.   Viruses-Basel

Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus

(2016) Shun Kaneko et al.   Scientific Reports

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes

(2016) Eloi R. Verrier et al.   Cell Reports

The FDA approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide

(2015) Chunkyu Ko et al.   ANTIVIRAL THERAPY

Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure

(2015) Mirjam B Zeisel et al.   GUT

A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses

(2015) Eloi R. Verrier et al.   HEPATOLOGY

Early inhibition of hepatocyte innate responses by hepatitis B virus

(2015) Souphalone Luangsay et al.   JOURNAL OF HEPATOLOGY

A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide

(2015) Manabu Kaneko et al.   JOURNAL OF VIROLOGY

Long-term culture and expansion of primary human hepatocytes

(2015) Gahl Levy et al.   NATURE BIOTECHNOLOGY

Interleukin 6 inhibits HBV entry through NTCP down regulation

(2015) Fidaa Bouezzedine et al.   VIROLOGY

Host-targeting agents for treatment of hepatitis B virus infection

(2015) Thomas F Baumert et al.   Current Opinion in Virology

Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle

(2014) Matthieu Blanchet et al.   ANTIVIRAL RESEARCH

Role of protein kinase C isoforms in bile formation and cholestasis

(2014) M. Sawkat Anwer   HEPATOLOGY

Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems

(2014) A. Shlomai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus

(2014) Chi-Ruei Huang   WORLD JOURNAL OF GASTROENTEROLOGY

Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP

(2013) Masashi Iwamoto et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes

(2013) Yi Ni et al.   GASTROENTEROLOGY

Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor

(2013) Shirin Nkongolo et al.   JOURNAL OF HEPATOLOGY

Molecular Determinants of Hepatitis B and D Virus Entry Restriction in Mouse Sodium Taurocholate Cotransporting Polypeptide

(2013) H. Yan et al.   JOURNAL OF VIROLOGY

The HepaRG cell line: a uniquein vitrotool for understanding drug metabolism and toxicology in human

(2012) Tommy B Andersson et al.   Expert Opinion on Drug Metabolism & Toxicology

A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A-determinant

(2012) Camille Sureau et al.   HEPATOLOGY

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

(2012) Huan Yan et al.   eLife

The Pre-S1 and Antigenic Loop Infectivity Determinants of the Hepatitis B Virus Envelope Proteins Are Functionally Independent

(2009) Y. Le Duff et al.   JOURNAL OF VIROLOGY